Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
KOO.L
Strong BuyFull HouseAPPROVEKooth plc · Healthcare · United Kingdom · $96M · Avg Vol: $272K/d
Meets eligibility requirements and features positive forward-EPS revisions. As a healthcare software play, it benefits from the structural shift toward efficient, digitally-delivered care models.
COMPANY DESCRIPTION
Kooth plc is a leading digital mental health platform provider in the UK, delivering anonymous, clinically validated support to youth and adults. The company holds a dominant market position as the primary digital mental health partner for the NHS, covering over 60% of NHS Integrated Care Boards. Its scalable, SaaS-like B2B model is expanding internationally, notably securing major state-wide contracts in the United States.
FINANCIAL SUMMARY (GBP)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 20.1M | 33.3M | 66.7M | 63.3M | 46.5% | 63.3M | 63.1M | 61.7M | -1.2% |
| EPS (GBp) | -1.00 | -0.02 | -0.49 | 21.91 | 7.24 | -67.0% | 7.00 | 7.47 | 9.43 | 14.1% |
| Shares | — | 33.1M | 36.5M | 36.7M | 36.0M | +9.0% | 36.3M | — | — | — |
| Debt | — | 68.0K | 44.0K | 23.0K | 0 | -41.8% | — | — | — | — |
| Equity | — | 10.5M | 20.8M | 29.8M | 31.6M | 44.3% | — | — | — | — |
| Op CF | — | 4.4M | 1.9M | 17.1M | 5.6M | 7.8% | 5.6M | — | — | — |
| Inv CF | — | -3.0M | -8.7M | -6.3M | -3.7M | — | — | — | — | — |
| Fin CF | — | 0 | 9.4M | 0 | -1.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of KOO.L are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| KOO.L | Kooth plc(you) | $96M | 95 | Strong Buy |
| DXRX.L | Diaceutics PLC | $164M | 66 | Buy |
| OPT.L | Optima Health plc | $359M | 63 | Hold |
| CRW.L | Craneware plc | $646M | 62 | Hold |
| MPAL.L | MedPal AI PLC | $46M | 13 | Strong Sell |
| EAH.L | ECO Animal Health Group plc | $89M | 94 | Strong Buy |
| RENX.L | Renalytix Plc | $25M | 15 | Strong Sell |
| BVXP.L | Bioventix PLC | $122M | 99 | Strong Buy |
| EKF.L | EKF Diagnostics Holdings plc | $147M | 85 | Strong Buy |
| TSTL.L | Tristel plc | $272M | 94 | Strong Buy |
Peer medians: ROE -4.1% · P/E 24.3x · Gross margin 55.3%